1. Molecular Bases of Drug Resistance in Hepatocellular Carcinoma
   Jose J.G. Marin et al, 2020, Cancers CrossRef
2. Mismatch repair genes (hMLH1,hPMS1,hPMS2,GTBP/hMSH6,hMSH2) in the pathogenesis of hepatocellular carcinoma
   Abdel-Rahman N. Zekri, 2005, World Journal of Gastroenterology CrossRef
3. A novel DNA damage response mediated by DNA mismatch repair in Caenorhabditis elegans: induction of programmed autophagic cell death in non-dividing cells
   Takahito Moriwaki et al, 2015, Genes & Cancer CrossRef
4. CDK2AP1 influences immune infiltrates and serves as a prognostic indicator for hepatocellular carcinoma
   Yibin Che et al, 2022, Frontiers in Genetics CrossRef
5. Clinicopathologic and Pedigree Differences in Amsterdam I–Positive Hereditary Nonpolyposis Colorectal Cancer Families According to Tumor Microsatellite Instability Status
   Laura Valle et al, 2007, Journal of Clinical Oncology CrossRef
6. DNA methylation in hepatocellular carcinoma
   Iris Tischoff, 2008, World Journal of Gastroenterology CrossRef
7. Protein profiles reveal MSH6/MSH2 as a potential biomarker for hepatocellular carcinoma with microvascular invasion
   Shengqian Hong et al, 2024, Hepatology Research CrossRef
8. Personalized treatment for hepatocellular carcinoma: Current status and future perspectives
   Stephen L Chan et al, 2022, Journal of Gastroenterology and Hepatology CrossRef
9. MTHFR Knockdown Assists Cell Defense against Folate Depletion Induced Chromosome Segregation and Uracil Misincorporation in DNA
   Ming-Tsung Wu et al, 2021, International Journal of Molecular Sciences CrossRef
10. Long noncoding RNA RP11-241J12.3 targeting pyruvate carboxylase promotes hepatocellular carcinoma aggressiveness by disrupting pyruvate metabolism and the DNA mismatch repair system
    Liuliu Cheng et al, 2022, Molecular Biomedicine CrossRef